Genetic Risk Test
HLA-DR genetic risk context for mold-related illness
The HLA-DR/DQ test can help contextualize genetic susceptibility as one clue in a broader clinical and environmental picture.
Listed price
$224 listed
Method
LabCorp blood draw
Results
Typically 2-3 weeks after collection
Availability
Available in most U.S. states except NY, NJ, HI, and RI in the current catalog.
Best fit
Use this test when it can answer the right question.
MoldCo keeps the test lane explicit so a home question, body question, and susceptibility question do not get collapsed into one claim.
People with persistent symptoms despite leaving exposure.
Patients who want susceptibility context once, since HLA type does not change.
Care conversations where recovery expectations and recurrence risk need more context.
What it measures
- HLA-DR/DQ genotype context.
- Susceptibility signals discussed in the CIRS and mold-related illness literature.
- Risk context, not current exposure level.
What it cannot prove
- Diagnosing mold-related illness.
- Measuring whether the home is contaminated.
- Predicting an exact recovery timeline.
How it works
From order to interpretation
Order the test if genetic context would change the conversation.
Complete the LabCorp blood draw.
Receive results after lab processing.
Interpret the result as one non-changing risk-context signal.
Before you order
These answers keep the clinical boundary clear: useful context, not a standalone diagnosis.
Does HLA-DR mean I will get sick from mold?
No. It helps explain susceptibility, not certainty. Exposure level, health history, and total clinical context still matter.
Do I need to repeat HLA testing?
No. HLA type is genetic context and does not change over time.
Not sure this is the right next step?
Take the Mold Risk Score first, or start care and let a provider help decide whether testing is useful.